nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—bone cancer	0.739	1	CbGaD
Ketorolac—PTGS2—Cisplatin—bone cancer	0.079	1	CbGbCtD
Ketorolac—Mebendazole—TUBB4B—bone cancer	0.00532	0.564	CrCbGaD
Ketorolac—Tiaprofenic acid—PTGS2—bone cancer	0.000633	0.0672	CrCbGaD
Ketorolac—Nepafenac—PTGS2—bone cancer	0.000603	0.0639	CrCbGaD
Ketorolac—Mebendazole—CYP3A4—bone cancer	0.000577	0.0611	CrCbGaD
Ketorolac—Fenbufen—PTGS2—bone cancer	0.000576	0.0611	CrCbGaD
Ketorolac—Salsalate—PTGS2—bone cancer	0.000501	0.0531	CrCbGaD
Ketorolac—Tolmetin—PTGS2—bone cancer	0.000501	0.0531	CrCbGaD
Ketorolac—Suprofen—PTGS2—bone cancer	0.00048	0.0509	CrCbGaD
Ketorolac—Ketoprofen—PTGS2—bone cancer	0.000244	0.0259	CrCbGaD
Ketorolac—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000196	0.00114	CcSEcCtD
Ketorolac—Hypersensitivity—Cisplatin—bone cancer	0.000196	0.00114	CcSEcCtD
Ketorolac—Bradycardia—Epirubicin—bone cancer	0.000196	0.00114	CcSEcCtD
Ketorolac—Renal failure—Doxorubicin—bone cancer	0.000195	0.00113	CcSEcCtD
Ketorolac—Erythema multiforme—Methotrexate—bone cancer	0.000194	0.00113	CcSEcCtD
Ketorolac—Haemoglobin—Epirubicin—bone cancer	0.000193	0.00112	CcSEcCtD
Ketorolac—Stomatitis—Doxorubicin—bone cancer	0.000193	0.00112	CcSEcCtD
Ketorolac—Jaundice—Doxorubicin—bone cancer	0.000193	0.00112	CcSEcCtD
Ketorolac—Rhinitis—Epirubicin—bone cancer	0.000193	0.00112	CcSEcCtD
Ketorolac—Conjunctivitis—Doxorubicin—bone cancer	0.000193	0.00112	CcSEcCtD
Ketorolac—Hepatitis—Epirubicin—bone cancer	0.000192	0.00112	CcSEcCtD
Ketorolac—Haemorrhage—Epirubicin—bone cancer	0.000192	0.00112	CcSEcCtD
Ketorolac—Eye disorder—Methotrexate—bone cancer	0.000192	0.00112	CcSEcCtD
Ketorolac—Tinnitus—Methotrexate—bone cancer	0.000191	0.00111	CcSEcCtD
Ketorolac—Asthenia—Cisplatin—bone cancer	0.000191	0.00111	CcSEcCtD
Ketorolac—Cardiac disorder—Methotrexate—bone cancer	0.000191	0.00111	CcSEcCtD
Ketorolac—Sweating—Doxorubicin—bone cancer	0.00019	0.0011	CcSEcCtD
Ketorolac—Urinary tract disorder—Epirubicin—bone cancer	0.00019	0.0011	CcSEcCtD
Ketorolac—Haematuria—Doxorubicin—bone cancer	0.000189	0.0011	CcSEcCtD
Ketorolac—Connective tissue disorder—Epirubicin—bone cancer	0.000189	0.0011	CcSEcCtD
Ketorolac—Urethral disorder—Epirubicin—bone cancer	0.000188	0.0011	CcSEcCtD
Ketorolac—Hepatobiliary disease—Doxorubicin—bone cancer	0.000187	0.00109	CcSEcCtD
Ketorolac—Epistaxis—Doxorubicin—bone cancer	0.000187	0.00109	CcSEcCtD
Ketorolac—Angiopathy—Methotrexate—bone cancer	0.000186	0.00108	CcSEcCtD
Ketorolac—Immune system disorder—Methotrexate—bone cancer	0.000185	0.00108	CcSEcCtD
Ketorolac—Visual impairment—Epirubicin—bone cancer	0.000185	0.00108	CcSEcCtD
Ketorolac—Mediastinal disorder—Methotrexate—bone cancer	0.000185	0.00108	CcSEcCtD
Ketorolac—Agranulocytosis—Doxorubicin—bone cancer	0.000185	0.00107	CcSEcCtD
Ketorolac—Chills—Methotrexate—bone cancer	0.000184	0.00107	CcSEcCtD
Ketorolac—Diarrhoea—Cisplatin—bone cancer	0.000182	0.00106	CcSEcCtD
Ketorolac—Erythema multiforme—Epirubicin—bone cancer	0.000182	0.00106	CcSEcCtD
Ketorolac—Alopecia—Methotrexate—bone cancer	0.000181	0.00105	CcSEcCtD
Ketorolac—Bradycardia—Doxorubicin—bone cancer	0.000181	0.00105	CcSEcCtD
Ketorolac—Mental disorder—Methotrexate—bone cancer	0.00018	0.00105	CcSEcCtD
Ketorolac—Eye disorder—Epirubicin—bone cancer	0.00018	0.00104	CcSEcCtD
Ketorolac—Tinnitus—Epirubicin—bone cancer	0.000179	0.00104	CcSEcCtD
Ketorolac—Erythema—Methotrexate—bone cancer	0.000179	0.00104	CcSEcCtD
Ketorolac—Malnutrition—Methotrexate—bone cancer	0.000179	0.00104	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—bone cancer	0.000179	0.00104	CcSEcCtD
Ketorolac—Flushing—Epirubicin—bone cancer	0.000178	0.00104	CcSEcCtD
Ketorolac—Cardiac disorder—Epirubicin—bone cancer	0.000178	0.00104	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—bone cancer	0.000178	0.00104	CcSEcCtD
Ketorolac—Haemorrhage—Doxorubicin—bone cancer	0.000178	0.00103	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—bone cancer	0.000178	0.00103	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—bone cancer	0.000176	0.00102	CcSEcCtD
Ketorolac—Dysgeusia—Methotrexate—bone cancer	0.000175	0.00102	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—bone cancer	0.000175	0.00102	CcSEcCtD
Ketorolac—Angiopathy—Epirubicin—bone cancer	0.000174	0.00101	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—bone cancer	0.000174	0.00101	CcSEcCtD
Ketorolac—Immune system disorder—Epirubicin—bone cancer	0.000174	0.00101	CcSEcCtD
Ketorolac—Mediastinal disorder—Epirubicin—bone cancer	0.000173	0.00101	CcSEcCtD
Ketorolac—Back pain—Methotrexate—bone cancer	0.000173	0.00101	CcSEcCtD
Ketorolac—Chills—Epirubicin—bone cancer	0.000172	0.001	CcSEcCtD
Ketorolac—Arrhythmia—Epirubicin—bone cancer	0.000172	0.000998	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—bone cancer	0.000171	0.000996	CcSEcCtD
Ketorolac—Alopecia—Epirubicin—bone cancer	0.00017	0.000987	CcSEcCtD
Ketorolac—Vomiting—Cisplatin—bone cancer	0.000169	0.000983	CcSEcCtD
Ketorolac—Vision blurred—Methotrexate—bone cancer	0.000168	0.000979	CcSEcCtD
Ketorolac—Mental disorder—Epirubicin—bone cancer	0.000168	0.000979	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—bone cancer	0.000168	0.000977	CcSEcCtD
Ketorolac—Rash—Cisplatin—bone cancer	0.000168	0.000975	CcSEcCtD
Ketorolac—Dermatitis—Cisplatin—bone cancer	0.000167	0.000974	CcSEcCtD
Ketorolac—Malnutrition—Epirubicin—bone cancer	0.000167	0.000973	CcSEcCtD
Ketorolac—Erythema—Epirubicin—bone cancer	0.000167	0.000973	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—bone cancer	0.000166	0.000966	CcSEcCtD
Ketorolac—Ill-defined disorder—Methotrexate—bone cancer	0.000166	0.000964	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—bone cancer	0.000166	0.000964	CcSEcCtD
Ketorolac—Anaemia—Methotrexate—bone cancer	0.000165	0.000961	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—bone cancer	0.000165	0.000959	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—bone cancer	0.000165	0.000959	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—bone cancer	0.000165	0.000958	CcSEcCtD
Ketorolac—Tension—Epirubicin—bone cancer	0.000164	0.000954	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—bone cancer	0.000164	0.000952	CcSEcCtD
Ketorolac—Nervousness—Epirubicin—bone cancer	0.000162	0.000945	CcSEcCtD
Ketorolac—Back pain—Epirubicin—bone cancer	0.000162	0.000941	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—bone cancer	0.000161	0.000938	CcSEcCtD
Ketorolac—Malaise—Methotrexate—bone cancer	0.000161	0.000937	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—bone cancer	0.000161	0.000934	CcSEcCtD
Ketorolac—Vertigo—Methotrexate—bone cancer	0.000161	0.000934	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—bone cancer	0.00016	0.000932	CcSEcCtD
Ketorolac—Leukopenia—Methotrexate—bone cancer	0.00016	0.00093	CcSEcCtD
Ketorolac—Chills—Doxorubicin—bone cancer	0.00016	0.000928	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—bone cancer	0.000159	0.000924	CcSEcCtD
Ketorolac—Nausea—Cisplatin—bone cancer	0.000158	0.000918	CcSEcCtD
Ketorolac—Vision blurred—Epirubicin—bone cancer	0.000158	0.000917	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—bone cancer	0.000157	0.000914	CcSEcCtD
Ketorolac—Cough—Methotrexate—bone cancer	0.000156	0.000907	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—bone cancer	0.000156	0.000906	CcSEcCtD
Ketorolac—Ill-defined disorder—Epirubicin—bone cancer	0.000155	0.000902	CcSEcCtD
Ketorolac—Convulsion—Methotrexate—bone cancer	0.000155	0.0009	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—bone cancer	0.000155	0.0009	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—bone cancer	0.000155	0.0009	CcSEcCtD
Ketorolac—Anaemia—Epirubicin—bone cancer	0.000155	0.000899	CcSEcCtD
Ketorolac—Agitation—Epirubicin—bone cancer	0.000154	0.000894	CcSEcCtD
Ketorolac—Flatulence—Doxorubicin—bone cancer	0.000153	0.000887	CcSEcCtD
Ketorolac—Myalgia—Methotrexate—bone cancer	0.000152	0.000885	CcSEcCtD
Ketorolac—Chest pain—Methotrexate—bone cancer	0.000152	0.000885	CcSEcCtD
Ketorolac—Arthralgia—Methotrexate—bone cancer	0.000152	0.000885	CcSEcCtD
Ketorolac—Tension—Doxorubicin—bone cancer	0.000152	0.000883	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—bone cancer	0.000152	0.000881	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000151	0.000879	CcSEcCtD
Ketorolac—Malaise—Epirubicin—bone cancer	0.000151	0.000877	CcSEcCtD
Ketorolac—Discomfort—Methotrexate—bone cancer	0.00015	0.000874	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—bone cancer	0.00015	0.000874	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—bone cancer	0.00015	0.000874	CcSEcCtD
Ketorolac—Syncope—Epirubicin—bone cancer	0.00015	0.000872	CcSEcCtD
Ketorolac—Leukopenia—Epirubicin—bone cancer	0.00015	0.000871	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—bone cancer	0.00015	0.00087	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—bone cancer	0.000148	0.000859	CcSEcCtD
Ketorolac—Confusional state—Methotrexate—bone cancer	0.000147	0.000855	CcSEcCtD
Ketorolac—Loss of consciousness—Epirubicin—bone cancer	0.000147	0.000855	CcSEcCtD
Ketorolac—Cough—Epirubicin—bone cancer	0.000146	0.000849	CcSEcCtD
Ketorolac—Anaphylactic shock—Methotrexate—bone cancer	0.000146	0.000848	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—bone cancer	0.000146	0.000848	CcSEcCtD
Ketorolac—Convulsion—Epirubicin—bone cancer	0.000145	0.000843	CcSEcCtD
Ketorolac—Infection—Methotrexate—bone cancer	0.000145	0.000843	CcSEcCtD
Ketorolac—Hypertension—Epirubicin—bone cancer	0.000144	0.00084	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—bone cancer	0.000144	0.000835	CcSEcCtD
Ketorolac—Nervous system disorder—Methotrexate—bone cancer	0.000143	0.000832	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—bone cancer	0.000143	0.000832	CcSEcCtD
Ketorolac—Thrombocytopenia—Methotrexate—bone cancer	0.000143	0.00083	CcSEcCtD
Ketorolac—Myalgia—Epirubicin—bone cancer	0.000142	0.000828	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—bone cancer	0.000142	0.000828	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—bone cancer	0.000142	0.000828	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—bone cancer	0.000142	0.000827	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—bone cancer	0.000142	0.000825	CcSEcCtD
Ketorolac—Skin disorder—Methotrexate—bone cancer	0.000142	0.000824	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000141	0.000822	CcSEcCtD
Ketorolac—Hyperhidrosis—Methotrexate—bone cancer	0.000141	0.00082	CcSEcCtD
Ketorolac—Discomfort—Epirubicin—bone cancer	0.000141	0.000818	CcSEcCtD
Ketorolac—Malaise—Doxorubicin—bone cancer	0.00014	0.000812	CcSEcCtD
Ketorolac—Dry mouth—Epirubicin—bone cancer	0.000139	0.00081	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—bone cancer	0.000139	0.000809	CcSEcCtD
Ketorolac—Anorexia—Methotrexate—bone cancer	0.000139	0.000809	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—bone cancer	0.000139	0.000807	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—bone cancer	0.000139	0.000806	CcSEcCtD
Ketorolac—Confusional state—Epirubicin—bone cancer	0.000138	0.0008	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—bone cancer	0.000137	0.000795	CcSEcCtD
Ketorolac—Oedema—Epirubicin—bone cancer	0.000137	0.000794	CcSEcCtD
Ketorolac—Anaphylactic shock—Epirubicin—bone cancer	0.000137	0.000794	CcSEcCtD
Ketorolac—Hypotension—Methotrexate—bone cancer	0.000136	0.000793	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—bone cancer	0.000136	0.000791	CcSEcCtD
Ketorolac—Infection—Epirubicin—bone cancer	0.000136	0.000789	CcSEcCtD
Ketorolac—Cough—Doxorubicin—bone cancer	0.000135	0.000785	CcSEcCtD
Ketorolac—Shock—Epirubicin—bone cancer	0.000134	0.000781	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—bone cancer	0.000134	0.00078	CcSEcCtD
Ketorolac—Nervous system disorder—Epirubicin—bone cancer	0.000134	0.000778	CcSEcCtD
Ketorolac—Thrombocytopenia—Epirubicin—bone cancer	0.000134	0.000777	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—bone cancer	0.000134	0.000777	CcSEcCtD
Ketorolac—Tachycardia—Epirubicin—bone cancer	0.000133	0.000775	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000133	0.000773	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—bone cancer	0.000133	0.000771	CcSEcCtD
Ketorolac—Hyperhidrosis—Epirubicin—bone cancer	0.000132	0.000767	CcSEcCtD
Ketorolac—Insomnia—Methotrexate—bone cancer	0.000132	0.000767	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—bone cancer	0.000132	0.000766	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—bone cancer	0.000132	0.000766	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—bone cancer	0.000132	0.000766	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—bone cancer	0.000131	0.000763	CcSEcCtD
Ketorolac—Paraesthesia—Methotrexate—bone cancer	0.000131	0.000762	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000131	0.000761	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—bone cancer	0.00013	0.000757	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—bone cancer	0.00013	0.000757	CcSEcCtD
Ketorolac—Dyspnoea—Methotrexate—bone cancer	0.00013	0.000756	CcSEcCtD
Ketorolac—Somnolence—Methotrexate—bone cancer	0.00013	0.000754	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—bone cancer	0.000129	0.000749	CcSEcCtD
Ketorolac—Dyspepsia—Methotrexate—bone cancer	0.000128	0.000747	CcSEcCtD
Ketorolac—Hypotension—Epirubicin—bone cancer	0.000128	0.000742	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—bone cancer	0.000127	0.000741	CcSEcCtD
Ketorolac—Decreased appetite—Methotrexate—bone cancer	0.000127	0.000737	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—bone cancer	0.000126	0.000734	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—bone cancer	0.000126	0.000734	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Methotrexate—bone cancer	0.000126	0.000732	CcSEcCtD
Ketorolac—Fatigue—Methotrexate—bone cancer	0.000126	0.000731	CcSEcCtD
Ketorolac—Infection—Doxorubicin—bone cancer	0.000126	0.00073	CcSEcCtD
Ketorolac—Pain—Methotrexate—bone cancer	0.000125	0.000725	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000124	0.000723	CcSEcCtD
Ketorolac—Shock—Doxorubicin—bone cancer	0.000124	0.000723	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—bone cancer	0.000124	0.00072	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—bone cancer	0.000124	0.000719	CcSEcCtD
Ketorolac—Insomnia—Epirubicin—bone cancer	0.000123	0.000718	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—bone cancer	0.000123	0.000717	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—bone cancer	0.000123	0.000713	CcSEcCtD
Ketorolac—Paraesthesia—Epirubicin—bone cancer	0.000123	0.000713	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—bone cancer	0.000122	0.00071	CcSEcCtD
Ketorolac—Dyspnoea—Epirubicin—bone cancer	0.000122	0.000708	CcSEcCtD
Ketorolac—Somnolence—Epirubicin—bone cancer	0.000121	0.000706	CcSEcCtD
Ketorolac—Anorexia—Doxorubicin—bone cancer	0.00012	0.0007	CcSEcCtD
Ketorolac—Feeling abnormal—Methotrexate—bone cancer	0.00012	0.000699	CcSEcCtD
Ketorolac—Dyspepsia—Epirubicin—bone cancer	0.00012	0.000699	CcSEcCtD
Ketorolac—Gastrointestinal pain—Methotrexate—bone cancer	0.000119	0.000694	CcSEcCtD
Ketorolac—Decreased appetite—Epirubicin—bone cancer	0.000119	0.00069	CcSEcCtD
Ketorolac—Hypotension—Doxorubicin—bone cancer	0.000118	0.000686	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Epirubicin—bone cancer	0.000118	0.000685	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—bone cancer	0.000118	0.000684	CcSEcCtD
Ketorolac—Pain—Epirubicin—bone cancer	0.000117	0.000679	CcSEcCtD
Ketorolac—Constipation—Epirubicin—bone cancer	0.000117	0.000679	CcSEcCtD
Ketorolac—Urticaria—Methotrexate—bone cancer	0.000116	0.000674	CcSEcCtD
Ketorolac—Abdominal pain—Methotrexate—bone cancer	0.000115	0.000671	CcSEcCtD
Ketorolac—Body temperature increased—Methotrexate—bone cancer	0.000115	0.000671	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000115	0.000669	CcSEcCtD
Ketorolac—Insomnia—Doxorubicin—bone cancer	0.000114	0.000664	CcSEcCtD
Ketorolac—Paraesthesia—Doxorubicin—bone cancer	0.000113	0.000659	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—bone cancer	0.000113	0.000655	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—bone cancer	0.000113	0.000654	CcSEcCtD
Ketorolac—Somnolence—Doxorubicin—bone cancer	0.000112	0.000653	CcSEcCtD
Ketorolac—Gastrointestinal pain—Epirubicin—bone cancer	0.000112	0.000649	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—bone cancer	0.000111	0.000647	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—bone cancer	0.00011	0.000638	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000109	0.000634	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—bone cancer	0.000109	0.000633	CcSEcCtD
Ketorolac—Urticaria—Epirubicin—bone cancer	0.000108	0.000631	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—bone cancer	0.000108	0.000628	CcSEcCtD
Ketorolac—Pain—Doxorubicin—bone cancer	0.000108	0.000628	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—bone cancer	0.000108	0.000627	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—bone cancer	0.000108	0.000627	CcSEcCtD
Ketorolac—Hypersensitivity—Methotrexate—bone cancer	0.000107	0.000625	CcSEcCtD
Ketorolac—Asthenia—Methotrexate—bone cancer	0.000105	0.000609	CcSEcCtD
Ketorolac—Feeling abnormal—Doxorubicin—bone cancer	0.000104	0.000605	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—bone cancer	0.000103	0.000601	CcSEcCtD
Ketorolac—Pruritus—Methotrexate—bone cancer	0.000103	0.0006	CcSEcCtD
Ketorolac—Hypersensitivity—Epirubicin—bone cancer	0.000101	0.000585	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—bone cancer	0.0001	0.000583	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—bone cancer	9.99e-05	0.000581	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—bone cancer	9.99e-05	0.000581	CcSEcCtD
Ketorolac—Diarrhoea—Methotrexate—bone cancer	9.98e-05	0.00058	CcSEcCtD
Ketorolac—Asthenia—Epirubicin—bone cancer	9.8e-05	0.00057	CcSEcCtD
Ketorolac—Pruritus—Epirubicin—bone cancer	9.66e-05	0.000562	CcSEcCtD
Ketorolac—Dizziness—Methotrexate—bone cancer	9.65e-05	0.000561	CcSEcCtD
Ketorolac—Diarrhoea—Epirubicin—bone cancer	9.34e-05	0.000543	CcSEcCtD
Ketorolac—Hypersensitivity—Doxorubicin—bone cancer	9.31e-05	0.000541	CcSEcCtD
Ketorolac—Vomiting—Methotrexate—bone cancer	9.28e-05	0.000539	CcSEcCtD
Ketorolac—Rash—Methotrexate—bone cancer	9.2e-05	0.000535	CcSEcCtD
Ketorolac—Dermatitis—Methotrexate—bone cancer	9.19e-05	0.000534	CcSEcCtD
Ketorolac—Headache—Methotrexate—bone cancer	9.14e-05	0.000531	CcSEcCtD
Ketorolac—Asthenia—Doxorubicin—bone cancer	9.06e-05	0.000527	CcSEcCtD
Ketorolac—Dizziness—Epirubicin—bone cancer	9.03e-05	0.000525	CcSEcCtD
Ketorolac—Pruritus—Doxorubicin—bone cancer	8.94e-05	0.00052	CcSEcCtD
Ketorolac—Vomiting—Epirubicin—bone cancer	8.68e-05	0.000505	CcSEcCtD
Ketorolac—PTGS2—periosteum—bone cancer	8.67e-05	0.209	CbGeAlD
Ketorolac—Nausea—Methotrexate—bone cancer	8.67e-05	0.000504	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—bone cancer	8.64e-05	0.000503	CcSEcCtD
Ketorolac—Rash—Epirubicin—bone cancer	8.61e-05	0.0005	CcSEcCtD
Ketorolac—Dermatitis—Epirubicin—bone cancer	8.6e-05	0.0005	CcSEcCtD
Ketorolac—Headache—Epirubicin—bone cancer	8.55e-05	0.000497	CcSEcCtD
Ketorolac—Dizziness—Doxorubicin—bone cancer	8.35e-05	0.000486	CcSEcCtD
Ketorolac—Nausea—Epirubicin—bone cancer	8.11e-05	0.000471	CcSEcCtD
Ketorolac—Vomiting—Doxorubicin—bone cancer	8.03e-05	0.000467	CcSEcCtD
Ketorolac—Rash—Doxorubicin—bone cancer	7.97e-05	0.000463	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—bone cancer	7.96e-05	0.000463	CcSEcCtD
Ketorolac—Headache—Doxorubicin—bone cancer	7.91e-05	0.00046	CcSEcCtD
Ketorolac—Nausea—Doxorubicin—bone cancer	7.5e-05	0.000436	CcSEcCtD
Ketorolac—PTGS2—leg—bone cancer	6.91e-05	0.167	CbGeAlD
Ketorolac—PTGS2—hindlimb—bone cancer	6.17e-05	0.149	CbGeAlD
Ketorolac—PTGS2—cartilage tissue—bone cancer	6.08e-05	0.147	CbGeAlD
Ketorolac—PTGS2—appendage—bone cancer	5.3e-05	0.128	CbGeAlD
Ketorolac—PTGS1—connective tissue—bone cancer	1.58e-05	0.0382	CbGeAlD
Ketorolac—PTGS2—connective tissue—bone cancer	1.51e-05	0.0365	CbGeAlD
Ketorolac—PTGS1—tendon—bone cancer	1.09e-05	0.0263	CbGeAlD
Ketorolac—PTGS1—spinal cord—bone cancer	1.05e-05	0.0253	CbGeAlD
Ketorolac—PTGS2—tendon—bone cancer	1.04e-05	0.0251	CbGeAlD
Ketorolac—PTGS2—bone marrow—bone cancer	1.01e-05	0.0243	CbGeAlD
Ketorolac—PTGS2—spinal cord—bone cancer	1e-05	0.0242	CbGeAlD
